Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 316,173 | 43,023 | 13.6 | 124,125 | 39.3 | 58,341 | 18.5 | 68,737 | 21.7 | 21,947 | 6.9 |
2015-2019 | 319,211 | 42,897 | 13.4 | 124,357 | 39.0 | 58,807 | 18.4 | 70,011 | 21.9 | 23,139 | 7.2 |
2014-2018 | 314,520 | 41,775 | 13.3 | 121,370 | 38.6 | 57,786 | 18.4 | 70,041 | 22.3 | 23,548 | 7.5 |
2013-2017 | 310,140 | 40,772 | 13.1 | 118,848 | 38.3 | 57,128 | 18.4 | 69,869 | 22.5 | 23,523 | 7.6 |
2012-2016 | 307,513 | 40,297 | 13.1 | 117,995 | 38.4 | 56,672 | 18.4 | 70,057 | 22.8 | 22,492 | 7.3 |
2011-2015 | 306,057 | 39,877 | 13.0 | 118,518 | 38.7 | 56,174 | 18.4 | 70,015 | 22.9 | 21,473 | 7.0 |
2010-2014 | 305,920 | 39,732 | 13.0 | 119,271 | 39.0 | 56,064 | 18.3 | 69,777 | 22.8 | 21,076 | 6.9 |
2009-2013 | 306,822 | 40,385 | 13.2 | 121,237 | 39.5 | 55,751 | 18.2 | 68,648 | 22.4 | 20,801 | 6.8 |
2008-2012 | 307,710 | 41,170 | 13.4 | 121,874 | 39.6 | 55,021 | 17.9 | 67,186 | 21.8 | 22,459 | 7.3 |
2007-2011 | 309,388 | 40,988 | 13.2 | 123,364 | 39.9 | 54,259 | 17.5 | 66,578 | 21.5 | 24,199 | 7.8 |
2006-2010 | 306,610 | 40,419 | 13.2 | 121,368 | 39.6 | 53,264 | 17.4 | 65,082 | 21.2 | 26,477 | 8.6 |
2005-2009 | 303,892 | 40,127 | 13.2 | 119,657 | 39.4 | 52,177 | 17.2 | 63,041 | 20.7 | 28,890 | 9.5 |
2004-2008 | 301,020 | 39,136 | 13.0 | 117,007 | 38.9 | 51,288 | 17.0 | 60,883 | 20.2 | 32,706 | 10.9 |
2003-2007 | 300,415 | 38,903 | 12.9 | 115,917 | 38.6 | 50,926 | 17.0 | 59,597 | 19.8 | 35,072 | 11.7 |
2002-2006 | 297,956 | 39,361 | 13.2 | 114,516 | 38.4 | 50,715 | 17.0 | 57,268 | 19.2 | 36,096 | 12.1 |
2001-2005 | 296,501 | 39,578 | 13.3 | 114,303 | 38.6 | 50,142 | 16.9 | 55,219 | 18.6 | 37,259 | 12.6 |
2000-2004 | 294,862 | 39,201 | 13.3 | 114,739 | 38.9 | 49,995 | 17.0 | 52,960 | 18.0 | 37,967 | 12.9 |
1999-2003 | 293,081 | 38,614 | 13.2 | 115,725 | 39.5 | 50,048 | 17.1 | 51,682 | 17.6 | 37,012 | 12.6 |
1998-2002 | 288,573 | 37,611 | 13.0 | 114,485 | 39.7 | 49,758 | 17.2 | 50,251 | 17.4 | 36,468 | 12.6 |
1997-2001 | 282,620 | 35,686 | 12.6 | 111,777 | 39.6 | 49,007 | 17.3 | 49,215 | 17.4 | 36,935 | 13.1 |
1996-2000 | 276,677 | 34,028 | 12.3 | 109,175 | 39.5 | 48,478 | 17.5 | 48,145 | 17.4 | 36,851 | 13.3 |
1995-1999 | 270,346 | 32,341 | 12.0 | 105,251 | 38.9 | 47,948 | 17.7 | 47,321 | 17.5 | 37,485 | 13.9 |
1994-1998 | 264,916 | 30,675 | 11.6 | 101,312 | 38.2 | 47,419 | 17.9 | 46,848 | 17.7 | 38,662 | 14.6 |
1993-1997 | 262,207 | 29,082 | 11.1 | 99,460 | 37.9 | 47,210 | 18.0 | 46,407 | 17.7 | 40,048 | 15.3 |
1992-1996 | 261,716 | 27,744 | 10.6 | 98,948 | 37.8 | 47,315 | 18.1 | 45,924 | 17.5 | 41,785 | 16.0 |
1991-1995 | 261,667 | 26,482 | 10.1 | 97,543 | 37.3 | 47,284 | 18.1 | 45,776 | 17.5 | 44,582 | 17.0 |
1990-1994 | 259,175 | 25,328 | 9.8 | 94,977 | 36.6 | 46,894 | 18.1 | 45,738 | 17.6 | 46,238 | 17.8 |
1989-1993 | 254,334 | 24,059 | 9.5 | 90,782 | 35.7 | 46,231 | 18.2 | 45,723 | 18.0 | 47,539 | 18.7 |
1988-1992 | 244,510 | 22,612 | 9.2 | 85,420 | 34.9 | 45,379 | 18.6 | 45,046 | 18.4 | 46,053 | 18.8 |
1987-1991 | 233,171 | 21,333 | 9.1 | 79,006 | 33.9 | 43,129 | 18.5 | 44,087 | 18.9 | 45,616 | 19.6 |
1986-1990 | 220,545 | 19,648 | 8.9 | 73,375 | 33.3 | 41,305 | 18.7 | 43,134 | 19.6 | 43,083 | 19.5 |
1985-1989 | 211,027 | 18,032 | 8.5 | 70,414 | 33.4 | 39,843 | 18.9 | 42,494 | 20.1 | 40,244 | 19.1 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |